Increased risk of AEs with higher ritonavir concentrations

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 1999年 / 781卷 / 1期
关键词：
Plasma Concentration; Drug Exposure; Ritonavir; Therapeutic Drug; Therapeutic Drug Monitoring;
D O I：
10.2165/00128415-199907810-00007
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [41] Nirmatrelvir+ritonavir-related AEs in patients with COVID-19 infections
    Reactions Weekly, 2023, 1957 (1) : 11 - 11
  • [42] Correlation of ritonavir free and total concentrations in plasma and saliva
    Burhenne, J
    Raschke, A
    Riedel, KD
    Ding, R
    Mikus, G
    Haefeli, WE
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (07) : S79 - S79
  • [43] Higher Plasma Selenium Concentrations Are Associated with Increased Odds of Prevalent Type 2 Diabetes
    Kohler, Lindsay N.
    Florea, Ana
    Kelley, Connor P.
    Chow, Sherry
    Hsu, Paul
    Batai, Ken
    Saboda, Kathylynn
    Lance, Peter
    Jacobs, Elizabeth T.
    JOURNAL OF NUTRITION, 2018, 148 (08): : 1333 - 1340
  • [44] Higher incidence of diarrhoea with nelfinavir than lopinavir/ritonavir
    Reactions Weekly, 2004, 1012 (1) : 5 - 5
  • [45] Circulating gastrin concentrations in patients at increased risk of developing colorectal carcinoma
    Paterson, Adrienne C.
    Macrae, Finlay A.
    Pizzey, Cathy
    Baldwin, Graham S.
    Shulkes, Arthur
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (03) : 480 - 486
  • [46] Are Higher Fasting Blood Concentrations Associated with Higher Risk for Developing Myocardial Infarction in Individuals Without Diabetes?
    Powers, Jennifer L.
    CLINICAL CHEMISTRY, 2018, 64 (03) : 615 - 616
  • [47] Risk factors for increased urinary inorganic arsenic concentrations from low arsenic concentrations in drinking water
    Hinwood, A
    Sim, M
    Jolley, D
    De Klerk, N
    Bastone, EB
    Gerostamoulos, J
    Drummer, OH
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH, 2003, 13 (03) : 271 - 284
  • [48] A comparative analysis of risk factors associated with efavirenz, darunavir/ritonavir, lopinavir/ritonavir, atazanavir/ritonavir and renal impairment
    Rockwood, N.
    Nelson, M.
    Mandalia, S.
    Sirokosta, J.
    Jones, R.
    Boffito, M.
    Gazzard, B.
    HIV MEDICINE, 2011, 12 : 1 - 1
  • [49] Fluoroquinolones: higher rate of AEs in paediatric patients
    Reactions Weekly, 2003, 960 (1) : 5 - 5
  • [50] Hepatitis risk with rifampicin + ritonavir/saquinavir
    Reactions Weekly, 2005, 1040 (1) : 4 - 4
12345